［1］ Sell S. Stem cell origin of cancer and differentiation therapy ［J］. Crit Rev Oncol Hematol，2004，51(1):1-28.
［2］Ponti D,Costa A,Zaffaroni N,et al.Isolation and in vitro  propagation of tumorigenic breast cancer cells with stem/progenitor cell properties ［J］. Cancer Res, 2005,65(13):5506-5511.
［3］Sagar J, Chaib B, Sales K, et al. Role of stem cells in cancer therapy and cancer stem cells: a review ［J］. Cancer Cell Int, 2007,7：9.
［4］Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors ［J］. Nat Genet, 2008,40(5):499-507.
［5］Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors ［J］. Cancer Res, 2003,63(18): 5821-5828. 
［6］Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors ［J］. Proc Natl Acad Sci USA, 2003, 100(25): 15178-15183. ［7］Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells ［J］. Cancer Cell, 2007,11(1):69-82.
［8］Beier D, Wischhusen J, Dietmaier W, et al. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors ［J］. Brain Pathol, 2008,18(3):370-377. 
［9］Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles ［J］. Cancer Res, 2007, 67(9):4010-4015.
［10］Purow BW, Haque RM, Noel MW, et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation ［J］. Cancer Res, 2005, 65(6): 2353-2363. 
［11］Ruizi Altaba A, Sanchez P,Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells ［J］. Nat Rev Cancer, 2002, 2(5): 361-372. 
［12］Dahmen RP, Koch A, Denkhaus D, et al. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas ［J］. Cancer Res, 2001, 61(19): 7039-7043. 
［13］Monk M, Holding C. Human embryonic genes re-expressed in cancer cells ［J］. Oncogene, 2001, 20(56): 8085-8091.
［14］Chang CC, Shieh GS, Wu P, et al. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells ［J］. Cancer Res, 2008, 68(15): 6281-6291. 
［15］Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma ［J］. Clin Cancer Res, 2008, 14(13): 4085-4095. 
［16］Hart AH, Hartley L, Ibrahim M, et al. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human ［J］. Dev Dyn, 2004,230(1):187-198.
［17］Jeter CR, Badeaux M, Choy G, et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development ［J］. Stem Cells, 2009,27(5):993-1005.［18］Hoei-Hansen CE, Sehested A, Juhler M, et al. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers ［J］. J Pathol, 2006,209(1):25-33.